Menu
Montecito
PacPremier
Loading...
You are here:  Home  >  'Prolia'  -  Page 2
Latest

Amgen reacquires rights to sell 3 drugs worldwide

By   /  Monday, December 14th, 2015  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Amgen reacquires rights to sell 3 drugs worldwide

Amgen reacquired all rights to sell three drugs worldwide on Dec. 14. The Thousand Oaks-based biotech giant said it reacquired the rights to Prolia, Vectibix and Xgeva in 48 ccountries from British pharmaceutical company GlaxoSmithKline. The agreement includes large countries like Australia, China and Brazil. Prolia is designed to raise bone density in people with Read More →

Read More →
Latest

Amgen bone density drug shows positive results

By   /  Monday, October 12th, 2015  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Amgen bone density drug shows positive results

Thousand Oaks-based pharmaceutical giant Amgen announced results Oct. 12 showing its bone density drug Prolia reduced the incidences of bone fractures in post-menopausal women with osteoporosis over 10 years. Prolia is designed to raise bone density in people with a history of osteoporosis. Amgen released the data during the annual conference of the American Society Read More →

Read More →